Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, Andreas, Grund, Stefanie, Mui, Barbara L, Hope, Michael J, Baumhof, Patrick, Fotin-Mleczek, Mariola, Schlake, Thomas·2015·Molecular Therapy

Cited by (514)

Items 101–200 of 514

  1. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
    Hongyu Chen, Dangliang Liu, Jianting Guo, Abhishek J. Aditham, Yiming Zhou, Jiakun Tian, Shuchen Luo, Jingyi Ren, Alvin Hsu, Jiahao Huang et al. · 2024 · Nature Biotechnology
  2. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
    Zhuoya Deng, Yuying Tian, Jianxun Song, Guangwen An, Penghui Yang · 2022 · Frontiers in Immunology
  3. mRNA therapeutics deliver a hopeful message
    Zifu Zhong, Séan Mc Cafferty, Francis Combes, Hanne Huysmans, Joyca De Temmerman, Arlieke Gitsels, Daisy C.G. Vanrompay, João Portela Catani, Niek N. Sanders · 2018 · Nano Today
  4. BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways
    Yingnan Geng, Huichuan Duan, Liang Xu, Nevin Witman, Bingqian Yan, Zheyuan Yu, Huijing Wang, Yao Tan, Liqin Lin, Dong Li et al. · 2021 · Communications Biology
  5. mRNA-Based Vaccines
    Frank Kowalzik, Daniel Schreiner, Christian Jensen, Daniel Teschner, Stephan Gehring, Fred Zepp · 2021 · Vaccines
  6. Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
    Erasmus, Jesse H., Archer, Jacob, Fuerte-Stone, Jasmine, Khandhar, Amit P., Voigt, Emily, Granger, Brian, Bombardi, Robin G., Govero, Jennifer, Tan, Qing, Durnell, Lorellin A. et al. · 2020 · Molecular Therapy - Methods & Clinical Development
  7. Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza
    Chivukula, Sudha, Plitnik, Timothy, Tibbitts, Timothy, Karve, Shrirang, Dias, Anusha, Zhang, Donghui, Goldman, Rebecca, Gopani, Hardip, Khanmohammed, Asad, Sarode, Ashish et al. · 2021 · npj Vaccines
  8. Development of mRNA Vaccines: Scientific and Regulatory Issues
    Knezevic, Ivana, Liu, Margaret A., Peden, Keith, Zhou, Tiequn, Kang, Hye-Na · 2021 · Vaccines
  9. Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
    Trepotec, Zeljka, Lichtenegger, Eva, Plank, Christian, Aneja, Manish K., Rudolph, Carsten · 2019 · Molecular Therapy
  10. Systemic mRNA delivery to the lungs by functional polyester-based carriers
    Yan, Yunfeng, Xiong, Hu, Zhang, Xinyi, Cheng, Qiang, Siegwart, Daniel J. · 2017 · Biomacromolecules
  11. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
    Ishtiaque Ahammad, Samia Sultana Lira · 2020 · International Journal of Biological Macromolecules
  12. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
    Javier Tadeo Granados-Riveron, Guillermo Aquino‐Jarquín · 2021 · Biomedicine & Pharmacotherapy
  13. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid‐Nanoparticle Components for Therapeutic and Vaccine Applications
    Kieu Lam, Ada Leung, Alan Martin, Mark Wood, Petra Schreiner, Lorne Palmer, Owen M. Daly, Wenchen Zhao, Kevin McClintock, James A. Heyes · 2023 · Advanced Materials
  14. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
    Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Sang‐Soo Lee · 2021 · Frontiers in Immunology
  15. mRNA: Fulfilling the Promise of Gene Therapy
    Drew Weissman, Katalin Karikó · 2015 · Molecular Therapy
  16. Advances in mRNA non-viral delivery approaches
    Maria Luigia Ibba, Giuseppe Ciccone, Carla Lucia Esposito, Silvia Catuogno, Paloma H. Giangrande · 2021 · Advanced Drug Delivery Reviews
  17. An overview of rational design of mRNA-based therapeutics and vaccines
    To, Kenneth K.W., Cho, William C.S. · 2021 · Expert Opinion on Drug Discovery
  18. Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
    Cynthia Aslan, Seyed Hossein Kiaie, Naime Majidi Zolbanin, Parisa Lotfinejad, Reihaneh Ramezani, Fatah Kashanchi, Reza Jafari · 2021 · BMC Biotechnology
  19. mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
    Maryam Bidram, Yue Zhao, Natalia G. Shebardina, Alexey V. Baldin, Alexandr V. Bazhin, Mohamad Reza Ganjalikhany, Andrey A. Zamyatnin, Mazdak Ganjalıkhani-Hakemi · 2021 · Vaccines
  20. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
    Pardi, Norbert, LaBranche, Celia C., Ferrari, Guido, Cain, Derek W., Tombácz, István, Parks, Robert J., Muramatsu, Hiromi, Mui, Barbara L., Tam, Ying K., Karikó, Katalin et al. · 2019 · Molecular Therapy - Nucleic Acids
  21. Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
    Sahu, Itishri, Haque, A.K.M. Ashiqul, Weidensee, Brian, Weinmann, Petra, Kormann, Michael S.D. · 2019 · Molecular Therapy
  22. Neo-Antigen mRNA Vaccines
    Arthur Esprit, Wout de Mey, Rajendra Bahadur Shahi, Kris Thielemans, Lorenzo Franceschini, Karine Breckpot · 2020 · Vaccines
  23. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
    Kowalczyk, Aleksandra, Doener, Fatma, Zanzinger, Kai, Noth, Janine, Baumhof, Patrick, Fotin-Mleczek, Mariola, Heidenreich, Regina · 2016 · Vaccine
  24. A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium
    Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan‐Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar‐Haim, Gonna Somu Naidu, Yael Diesendruck et al. · 2023 · Science Advances
  25. Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets
    Conway, Anthony, Mendel, Matthew, Kim, Kenneth, McGovern, Kyle, Boyko, Alisa, Zhang, Lei, Miller, Jeffrey C., DeKelver, Russell C., Paschon, David E., Mui, Barbara L. et al. · 2019 · Molecular Therapy
  26. Messenger RNA-Based Vaccines Against Infectious Diseases
    Alameh, Mohamad-Gabriel, Weissman, Drew, Pardi, Norbert · 2020 · Current Topics in Microbiology and Immunology
  27. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
    Kang, Diana D., Li, Haoyuan, Dong, Yizhou · 2023 · Advanced Drug Delivery Reviews
  28. Anti-PfGARP activates programmed cell death of parasites and reduces severe malaria
    Raj, Dipak K., Das Mohapatra, Alok, Jnawali, Anup, Zuromski, Jenna, Jha, Ambrish, Cham-Kpu, Gerald, Sherman, Brett, Rudlaff, Rachel M., Nixon, Christina E., Hilton, Nicholas et al. · 2020 · Nature
  29. Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
    Vivek P. Chavda, Md. Mer Mosharraf Hossain, Jayesh Beladiya, Vasso Apostolopoulos · 2021 · Biologics
  30. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine
    Xing Huang, Gang Zhang, Tianyu Tang, Xiang Gao, Tingbo Liang · 2022 · Military Medical Research
  31. Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
    Phei Er Saw, Erwei Song · 2024 · Cell Reports Medicine
  32. Recent innovations in mRNA vaccines
    Ulmer, Jeffrey B, Geall, Andrew J · 2016 · Current Opinion in Immunology
  33. Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
    Hojeong Shin, S.D. Park, Yeajee Yim, Jungho Kim, Chulwon Choi, Cheolhee Won, Dal‐Hee Min · 2018 · Advanced Therapeutics
  34. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
    Kevin O. Saunders, Norbert Pardi, Robert Parks, Sampa Santra, Zekun Mu, Laura L. Sutherland, Richard M. Scearce, Maggie Barr, Amanda Eaton, Giovanna E. Hernandez et al. · 2021 · npj Vaccines
  35. mRNA: A Novel Avenue to Antibody Therapy?
    Thomas Schlake, Moritz Thran, Katja Fiedler, Regina Heidenreich, Benjamin Petsch, Mariola Fotin‐Mleczek · 2019 · Molecular Therapy
  36. Peptide-mediated delivery of therapeutic mRNA in ovarian cancer
    Dirk van den Brand, Mark A.J. Gorris, Alexander H. van Asbeck, Emma Palmen, Inge M.W. Ebisch, Harry Dolstra, Mattias Hällbrink, Leon F.A.G. Massuger, Roland E. Brock · 2019 · European Journal of Pharmaceutics and Biopharmaceutics
  37. Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin
    Golombek, Sonia, Pilz, Martin, Steinle, Heidrun, Kochba, Efrat, Levin, Yotam, Lunter, Dominique, Schlensak, Christian, Wendel, Hans Peter, Avci-Adali, Meltem · 2018 · Molecular Therapy Nucleic Acids
  38. New Kids on the Block: RNA-Based Influenza Virus Vaccines
    Francesco Berlanda Scorza, Norbert Pardi · 2018 · Vaccines
  39. Frameworks for transformational breakthroughs in RNA-based medicines
    John R. Androsavich · 2024 · Nature Reviews Drug Discovery
  40. Synthetic circular RNA switches and circuits that control protein expression in mammalian cells
    Shigetoshi Kameda, Hirohisa Ohno, Hirohide Saito · 2023 · Nucleic Acids Research
  41. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
    Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda et al. · 2021 · Vaccines
  42. Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS
    Beverly, Michael, Dell, Amy, Parmar, Parul, Houghton, Leslie · 2016 · Analytical and Bioanalytical Chemistry
  43. Testing thousands of nanoparticles in vivo using DNA barcodes
    Melissa P. Lokugamage, Cory D. Sago, James E. Dahlman · 2018 · Current Opinion in Biomedical Engineering
  44. Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
    Katherine L. Mallory, Justin A. Taylor, Xiaoyan Zou, Ishita N. Waghela, Cosette G. Schneider, Michael Q. Sibilo, Neeraja M. Punde, Leah Perazzo, Tatyana Savransky, Martha Sedegah et al. · 2021 · npj Vaccines
  45. Engineering Gene Therapy: Advances and Barriers
    Alireza Shahryari, Ingo Burtscher, Zahra Nazari, Heiko Lickert · 2021 · Advanced Therapeutics
  46. In Vivo Introduction of mRNA Encapsulated in Lipid Nanoparticles to Brain Neuronal Cells and Astrocytes via Intracerebroventricular Administration
    Tanaka, Hiroki, Nakatani, Taichi, Furihata, Tomomi, Tange, Kota, Nakai, Yuta, Yoshioka, Hiroki, Harashima, Hideyoshi, Akita, Hidetaka · 2018 · Molecular Pharmaceutics
  47. mRNA in cancer immunotherapy: beyond a source of antigen
    Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Y. Vermaelen, Karine Breckpot, Sandra Van Lint · 2021 · Molecular Cancer
  48. The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives
    Shengbo Sun, Lanchun Liu, Jingkang Zhang, Liting Sun, Wenlong Shu, Zhengyang Yang, Hongwei Yao, Zhongtao Zhang · 2025 · Journal of Hematology & Oncology
  49. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
    Sittplangkoon, Chutamath, Alameh, Mohamad-Gabriel, Weissman, Drew, Lin, Paulo J. C., Tam, Ying K., Prompetchara, Eakachai, Palaga, Tanapat · 2022 · Frontiers in Immunology
  50. Oligonucleotide Sequence Mapping of Large Therapeutic mRNAs via Parallel Ribonuclease Digestions and LC-MS/MS
    Tao Jiang, Ningxi Yu, Jaeah Kim, John-Ross Murgo, Mildred Kissai, Kanchana R. Ravichandran, Edward J. Miracco, Vladimir Presnyak, Serenus S. Hua · 2019 · Analytical Chemistry
  51. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
    Sean C. Semple, Robert D. Leone, Christopher Barbosa, Ying K. Tam, Paulo J.C. Lin · 2022 · Pharmaceutics
  52. Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5′-UTRs
    Trepotec, Zeljka, Aneja, Manish K., Geiger, Johannes, Hasenpusch, Guenther, Plank, Christian, Rudolph, Carsten · 2019 · Tissue Engineering Part A
  53. Current view on novel vaccine technologies to combat human infectious diseases
    Zrinka Matić, Maja Šantak · 2021 · Applied Microbiology and Biotechnology
  54. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
    Li-Juan Duan, Qian Wang, Cuilian Zhang, Dong-Xiao Yang, Xuyao Zhang · 2022 · Frontiers in Immunology
  55. Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects
    Rao Fu, Ruoyao Qi, Hualong Xiong, Xing Lei, Yao Jiang, Jinhang He, Feng Chen, Liang Zhang, Dekui Qiu, Yiyi Chen et al. · 2024 · Signal Transduction and Targeted Therapy
  56. The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants
    Blakney, Anna K., McKay, Paul F., Ibarzo Yus, Bárbara, Hunter, Judith E., Dex, Elizabeth A., Shattock, Robin J. · 2019 · ACS Nano
  57. Emerging delivery approaches for targeted pulmonary fibrosis treatment
    Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, Md Nurunnabi · 2023 · Advanced Drug Delivery Reviews
  58. A “top-down” approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery
    Yuhang Jiang, Alice Gaudin, Junwei Zhang, Tushar Agarwal, Eric Song, Amy C. Kauffman, Gregory T. Tietjen, Yongheng Wang, Zhaozhong Jiang, Christopher J. Cheng et al. · 2018 · Biomaterials
  59. Delivery of therapeutic oligonucleotides in nanoscale
    Lei Wu, Wenhui Zhou, Lihua Lin, Anhong Chen, Jing Chun Feng, Xiangmeng Qu, Hongbo Zhang, Jun Yue · 2021 · Bioactive Materials
  60. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design
    Bruna Clemente, Maxime Denis, Camila Pedroso Silveira, Francesca Schiavetti, Michela Brazzoli, Daniela Stranges · 2023 · Frontiers in Immunology
  61. Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
    Roy van der Meel, Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Xu Ran S. Zhang, Ying K. Tam, Marcel B. Bally, Raymond Michel Schiffelers, Marco A. Ciufolini, Pieter R. Cullis et al. · 2021 · Small
  62. Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications
    H. Al Tbeishat · 2022 · Scientific Reports
  63. Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
    Ziqi Wang, Kai Cui, Ulrich Costabel, Xiaoju Zhang · 2022 · Exploration
  64. Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
    Ryuichi Mashima, Shuji Takada · 2022 · Current Issues in Molecular Biology
  65. Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
    Akbar Hasanzadeh, Michael Richard Hamblin, Jafar Kiani, Hamid Noori, Joseph Michael Hardie, Mahdi Karimi, Hadi Shafiee · 2022 · Nano Today
  66. mRNA: A promising platform for cancer immunotherapy
    Byoungjae Kong, Yelee Kim, Eun Hye Kim, Jung Soo Suk, Yoosoo Yang · 2023 · Advanced Drug Delivery Reviews
  67. Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids
    Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Igor V. Zhigaltsev, Ying K. Tam, Marco A. Ciufolini, Yuen Yi C. Tam, Pieter R. Cullis · 2018 · Journal of Controlled Release
  68. The use of design of experiments with multiple responses to determine optimal formulations for in vivo hepatic mRNA delivery
    Akari Hashiba, Manaya Toyooka, Yusuke Sato, Masatoshi Maeki, Manabu Tokeshi, Hideyoshi Harashima · 2020 · Journal of Controlled Release
  69. Advanced delivery systems for peptide antibiotics
    Angela Cesaro, Shuang‐Zhe Lin, Norbert Pardi, César de la Fuente‐Núñez · 2023 · Advanced Drug Delivery Reviews
  70. Codon-optimization in gene therapy: promises, prospects and challenges
    Anastasiia Iu. Paremskaia, Anna A. Kogan, Anastasiia Murashkina, Daria A. Naumova, Anakha Satish, Ivan S. Abramov, Sofya G. Feoktistova, Olga N. Mityaeva, Andrei A. Deviatkin, Pavel Volchkov · 2024 · Frontiers in Bioengineering and Biotechnology
  71. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
    Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, Vasso Apostolopoulos, Chirag Amrutlal Patel, Rajashri Bezbaruah, Aayushi Patel, Zhe‐Sheng Chen · 2022 · Frontiers in Immunology
  72. Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential
    Malwina Strenkowska, Renata Grzela, Maciej Majewski, Katarzyna Wnek, Joanna Kowalska, Maciej Łukaszewicz, Joanna Zuberek, Edward Darżynkiewicz, Andreas N. Kuhn, Uğur Şahin et al. · 2016 · Nucleic Acids Research
  73. mRNA-Based Therapeutics in Cancer Treatment
    Han Sun, Yu Zhang, Ge Wang, Wen Yang, Yingjie Xu · 2023 · Pharmaceutics
  74. The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system
    Marie‐Clotilde Bernard, Emilie Bazin, Nadine Petiot, Katia Lemdani, Sylvie Commandeur, Cécile Verdelet, Sylvie Margot, Vladimir Perkov, Manon Ripoll, Marie Garinot et al. · 2023 · Molecular Therapy — Nucleic Acids
  75. Therapeutic mRNA delivery to leukocytes
    Yasmin Granot-Matok, Edo Kon, Niels Dammes, Gilad Mechtinger, Dan Peer · 2019 · Journal of Controlled Release
  76. Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
    Cody S. Nelson, Jennifer Anne Jenks, Norbert Pardi, Matthew L. Goodwin, Hunter K. Roark, Whitney Edwards, Jason S. McLellan, Justin Pollara, Drew Weissman, Sallie R. Permar · 2020 · Journal of Virology
  77. Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
    Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, Amine Kamen · 2023 · Biomolecules
  78. Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
    Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao, Xingxing He · 2023 · Biomarker Research
  79. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
  80. Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines
    Maria L. Guevara, Stefano Persano, Francesca Persano · 2019 · Current Pharmaceutical Design
  81. RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines
    Rauch, Susanne, Lutz, Johannes, Kowalczyk, Aleksandra, Schlake, Thomas, Heidenreich, Regina · 2017 · Methods in Molecular Biology
  82. New Technologies for Influenza Vaccines
    Steven P. Rockman, Karen Laurie, Simone Parkes, Adam K. Wheatley, Ian Barr · 2020 · Microorganisms
  83. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
    Amanda L. Huff, Elizabeth M. Jaffee, Neeha Zaidi · 2022 · Journal of Clinical Investigation
  84. RNA vaccines for cancer: Principles to practice
    Pablo Guasp, Charlotte Reiche, Zachary M. Sethna, Vinod P. Balachandran · 2024 · Cancer Cell
  85. Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends
    Mariana Biscaia-Caleiras, Nuno André Fonseca, Ana Sofia Lourenço, João Nuno Moreira, Sérgio Simões · 2024 · Journal of Controlled Release
  86. Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
    Willis, Elinor, Pardi, Norbert, Parkhouse, Kaela, Mui, Barbara L., Tam, Ying K., Weissman, Drew, Hensley, Scott E. · 2020 · Science Translational Medicine
  87. Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
    Jie Tang, Larry Cai, Chuanfei Xu, Si Sun, Yuheng Liu, Joseph Rosenecker, Shan Guan · 2022 · Nanomaterials
  88. Branched hydrophobic tails in lipid nanoparticles enhance mRNA delivery for cancer immunotherapy
    Yunfeng Yan, Xiaomin Liu, Longyu Wang, Chengfan Wu, Qi Shuai, Yanmei Zhang, Shuai Liu · 2023 · Biomaterials
  89. VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
    Fatima Rizvi, Yu‐Ri Lee, Ricardo Díaz‐Aragon, Pushpinder Bawa, Juhoon So, Rodrigo Machado Florentino, Susan Y. Wu, Arianna Sarjoo, Emily Truong, Anna R. Smith et al. · 2023 · Cell stem cell
  90. Human RNase 4 improves mRNA sequence characterization by LC–MS/MS
    Eric J. Wolf, Sebastian Grünberg, Nan Dai, Tien-Hao Chen, Bijoyita Roy, Erbay Yigit, Ivan Reis Correa Junior · 2022 · Nucleic Acids Research
  91. Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
    Rebuma Firdessa-Fite, Rémi J. Creusot · 2019 · Molecular Therapy — Methods & Clinical Development
  92. mRNA vaccines: a new era in vaccine development
    Shubhra Chandra, Jennifer C Wilson, David M. Good, Ming Qian Wei · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  93. De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells
    Lescan, Mario, Perl, Regine Mariette, Golombek, Sonia, Pilz, Martin, Hann, Ludmilla, Yasmin, Mahua, Behring, Andreas, Keller, Timea, Nolte, Andrea, Gruhn, Franziska et al. · 2018 · Molecular Therapy Nucleic Acids
  94. Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors
    Cheng Huang, Xing Duan, Jichao Wang, Qingqing Tian, Yangmei Ren, Kepan Chen, Zongliang Zhang, Yuanyou Li, Yunyu Feng, Kunhong Zhong et al. · 2022 · Advanced Science
  95. Design and assessment of engineered CRISPR–Cpf1 and its use for genome editing
    Bin Li, Chunxi Zeng, Yizhou Dong · 2018 · Nature Protocols
  96. Therapeutic mRNA Engineering from Head to Tail
    Longfei Jia, Shu‐Bing Qian · 2021 · Accounts of Chemical Research
  97. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses
    Ye Zeng, Oscar Escalona-Rayo, Renzo A. Knol, Alexander Kros, Bram Slütter · 2022 · Biomaterials Science
  98. An Update on mRNA-Based Viral Vaccines
    Subbiah Jeeva, Ki‐Hye Kim, Chong Hyun Shin, Bao‐Zhong Wang, Sang‐Moo Kang · 2021 · Vaccines
  99. mRNA vaccines in the prevention and treatment of diseases
    Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang, Xing Zhao · 2022 · MedComm
  100. An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations
    Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, Behnaz Bakhshandeh, Ramezan Ali Taheri, Hoorieh Soleimanjahi, Reza Zolfaghari Emameh · 2023 · International Immunopharmacology